4:20 pm : The market closed higher for a second straight day, showing resilience in the face of renewed inflation fears, rising bond yields and record oil prices, as strong earnings across the board ultimately sidelined the bears. Before 8:00 ET, all signs pointed to the market adding to its biggest gain in nearly a year, as the bulk of earnings reports since yesterday's close either matched or surpassed Wall Street's forecasts. In fact, of the 12 Dow components reporting this week, the five blue chips posting results this morning all beat expectations.
A Real Nut Case New research is making a strong case in favor of adding more nuts to your diet.
more
General Health Tip
Eat To Protect Your Eyes. What you eat can go a long way toward protecting your vision as you get older. Focus on foods with natural yellow pigments and those rich in vitamins C and E to keep your vision in top shape.
More
NATALEE'S UNCLE SAYS 'RE-ARREST DEEPAK!'
Natalee Holloway's uncle is demanding that suspect Deepak Kalpoe be re-arrested in the 10-month-old mystery of the pretty blonde honor student who disappeared in Aruba. Deepak, his brother Satish and Joran van der Sloot were with the Alabama teen, pictured center, when she was last seen leaving a bar on the island in the early hours of May 30. Her uncle Paul Reynolds told The National Enquirer that he believes Deepak, 21, should be the chief suspect instead of van der Sloot, 18. Reynolds also... STAR JONES CHEATS DEATH AS SHE UNDERGOES PLASTIC SURGERY A WILD NIGHT OUT FOR JESSE & HIS PARTY PAL LINDSAY
Star Magazine
KATIE HOLMES: FEARING FOR HER TOMKITTEN
Katie Holmes was already worried about the upcoming birth of her baby. According to the tenets of 43-year-old fiancé Tom Cruise's religion, Scientology, she'll have to be silent (not even a moan!) during the delivery, lest the trauma be imprinted in her baby's brain. Plus, a source says, "Only Tom and a few Scientology supporters will be in the room — not Katie's mother!" And Scientology advocates separating the baby from its mother for at least the first 24 hours after birth. Now... IT'S OVER! KRISTIN CHEATS ON NICK WITH HER EX! ANGELINA PILOTING HER PLANE AT 7 1/2 MONTHS: IS SHE CRAZY?
Pentagon Releases Extensive Gitmo List In this April 5, 2006 file photo, reviewed by US military officials, a detainee is transported by U.S. Navy personnel into a building within the grounds of the maximum security prison at Camp Delta 2 & 3, at the Guantanamo Bay Naval Base, Cuba. A list with 558 people, the first official roster of Guantanamo detainees who passed through the Combatant Status Review Tribunal process in 2004 and 2005 that determine whether they should be deemed "enemy combatants", was released by the Pentagon late Wednesday, April 19, 2006. (AP Photo/Brennan Linsley, file)
3:09 pm PT Energy Partners announces departure of David Looney as Chief Financial Officer (EPL) 28.70 +.48 : Co announces David Looney, Executive�VP and Chief Financial Officer, has submitted his resignation in order to pursue professional opportunities in Houston, where his family has remained since Katrina.
2:49 pm PT Bill Barrett treasurer, Robert Howard, to resign 8-K (BBG) 33.00 +0.85 : �
2:41 pm PT Teva Pharm district court denies Apotex's request to block Teva's introduction of first generic Pravachol in the U.S (TEVA) 39.31 : Co announces�that the U.S. District Court for the District of Columbia has denied Apotex's motion for a temporary restraining order and preliminary injunction relating to Apotex's challenge to Teva's 180 days of marketing exclusivity for the first generic version of Bristol-Myers Squibb's (BMY)�Pravachol (pravastatin sodium) Tablets in the United States. At Apotex's request, the Court has ordered the FDA to refrain from issuing a final approval for the co's Abbreviated New Drug Application for generic pravastatin 10, 20 and 40 mg strengths until after 5:00 pm on Friday, April 21, 2006, in order to give Apotex an opportunity to appeal today's ruling in favor of the co. The co had expected to receive final approval with exclusivity on April 20, 2006 when the product patent expires. As previously announced on April 12, 2006, the FDA denied Apotex's request for an agency determination that 180-day exclusivity for pravastatin 10, 20, and 40 mg had been triggered and run.